NCT00121290View on ClinicalTrials.gov

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

SJG-136

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

37232

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00121290 - SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter